CMX001 for prevention and control of CMV infection in CMV-seropositive allogeneic stem-cell transplant recipients: A phase 2 randomized, double-blind, placebo-controlled, dose-escalation trial of safety, tolerability and antiviral activity Meeting Abstract
| Authors: | Marty, F. M.; Winston, D.; Rowley, S. D.; Boeckh, M.; Vance, E.; Papanicolaou, G.; Robertson, A.; Godkin, S.; Painter, W. |
| Abstract Title: | CMX001 for prevention and control of CMV infection in CMV-seropositive allogeneic stem-cell transplant recipients: A phase 2 randomized, double-blind, placebo-controlled, dose-escalation trial of safety, tolerability and antiviral activity |
| Meeting Title: | 2012 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 18 |
| Issue: | 2 Suppl. 2 |
| Meeting Dates: | 2012 Feb 1-5 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-02-01 |
| Start Page: | S203 |
| End Page: | S204 |
| Language: | English |
| ACCESSION: | WOS:000299398600006 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2011.12.004 |
| Notes: | - CIBMTR Best Abstract Awards for Clinical Research - Meeting Abstract: 5 - BMT Tandem Meeting - FEB 01-05, 2012 - San Diego, CA - "2" - "Source: Wos" |
